D
DiaMedica Therapeutics Inc. DMAC
$3.77 -$0.08-2.08% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024 03/31/2024
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses 20.48% -10.23% 0.80% -22.20% 8.51%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 41.86% 43.96% 33.47% 18.92% 3.98%
Operating Income -41.86% -43.96% -33.47% -18.92% -3.98%
Income Before Tax -49.71% -53.55% -40.39% -14.36% 2.30%
Income Tax Expenses -14.29% -59.09% 0.00% 0.00% 0.00%
Earnings from Continuing Operations -49.62% -53.07% -40.33% -14.34% 2.30%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -49.62% -53.07% -40.33% -14.34% 2.30%
EBIT -41.86% -43.96% -33.47% -18.92% -3.98%
EBITDA -41.86% -43.97% -33.48% -18.88% -3.97%
EPS Basic -32.57% -35.94% -24.62% 17.94% 31.91%
Normalized Basic EPS -32.59% -36.33% -24.63% 17.99% 31.91%
EPS Diluted -32.57% -35.94% -24.62% 17.94% 31.91%
Normalized Diluted EPS -32.59% -36.33% -24.63% 17.99% 31.91%
Average Basic Shares Outstanding 12.87% 12.61% 12.65% 39.38% 43.51%
Average Diluted Shares Outstanding 12.87% 12.61% 12.65% 39.38% 43.51%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --